Skip to main content
Equibles

Qube Research & Technologies Ltd

Position in ZYME — Zymeworks Inc.

CIK 1729829 LONDON, X0
Back to ZYME Full portfolio

Position in ZYME

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$15,516,442
+$2,697,540 QoQ
Shares Held
593,590
+15.9% QoQ
Ownership
0.837%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#18
of 202 holders
Holding Since
Mar 2023
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ZYME Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Qube Research & Technologies Ltd holds $2,437,858,262 across 168 Biotechnology names. ZYME ranks #34 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ALNY
Alnylam Pharmaceuticals, Inc.
 798,715 $240,437,176
2 INSM
INSMED Inc
 1,682,334 $179,370,451
3 REGN
Regeneron Pharmaceuticals, Inc.
 221,607 $138,180,828
4 ROIV
Roivant Sciences Ltd.
 3,454,496 $122,254,613
5 AXSM
Axsome Therapeutics, Inc.
 426,336 $104,354,262
6 APGE
Apogee Therapeutics, Inc.
 659,678 $87,559,060
7 TVTX
Travere Therapeutics, Inc.
 1,443,230 $81,989,896
8 RPRX
Royalty Pharma plc
 1,412,112 $79,177,119

All Filings in ZYME

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $15,516,442 593,590
2026-03-31 $12,818,902 511,937
2025-12-31 $12,488,055 474,290
2025-09-30 $4,355,434 255,002
2025-06-30 $876,918 69,874
2024-12-31 $320,147 21,868
2024-06-30 $862,896 101,398
2024-03-31 $1,686,345 160,299
2023-12-31 $684,804 65,910
2023-09-30 $603,999 95,268
2023-06-30 $619,833 71,740
2023-03-31 $1,548,678 171,314